This company listing is no longer active
6HL Stock Overview
Provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
R1 RCM Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$18.70 |
| 52 Week High | US$25.00 |
| 52 Week Low | US$15.90 |
| Beta | 0.87 |
| 1 Month Change | -7.43% |
| 3 Month Change | -17.26% |
| 1 Year Change | 0% |
| 3 Year Change | 73.82% |
| 5 Year Change | 476.98% |
| Change since IPO | 77.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6HL | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.1% | 1.3% | 1.4% |
| 1Y | 0% | 19.2% | 9.1% |
Return vs Industry: 6HL exceeded the German Healthcare industry which returned -30.4% over the past year.
Return vs Market: 6HL exceeded the German Market which returned -20.7% over the past year.
Price Volatility
| 6HL volatility | |
|---|---|
| 6HL Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6HL's share price has been volatile over the past 3 months.
Volatility Over Time: 6HL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 21,400 | Joe Flanagan | www.r1rcm.com |
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services.
R1 RCM Inc. Fundamentals Summary
| 6HL fundamental statistics | |
|---|---|
| Market cap | €7.86b |
| Earnings (TTM) | €95.15m |
| Revenue (TTM) | €1.43b |
82.6x
P/E Ratio5.5x
P/S RatioIs 6HL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6HL income statement (TTM) | |
|---|---|
| Revenue | US$1.52b |
| Cost of Revenue | US$1.19b |
| Gross Profit | US$325.60m |
| Other Expenses | US$224.80m |
| Earnings | US$100.80m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 21.45% |
| Net Profit Margin | 6.64% |
| Debt/Equity Ratio | 209.6% |
How did 6HL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/22 15:02 |
| End of Day Share Price | 2022/06/21 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
R1 RCM Inc. is covered by 27 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Michael Cherny | BofA Global Research |
| Bret Jones | Brean Capital |